CXCL13+CD8+ T cells have been described as tumor-reactive cells triggered by immune-checkpoint blockade (28), but to our knowledge, this population has not previously been demonstrated to contribute to skin inflammation. This evidence concerns the gene CXCL13 and neoplasm.